There are millions of fungal species, and a few hundred of them can make people very sick.1
Antifungal drugs treat fungal infections by killing or stopping the growth of dangerous fungi in the body. However, fungi, like bacteria, can develop antibiotic resistance, when germs develop the ability to defeat the drugs designed to kill them.2
Some types of fungi, like Candida auris, can be resistant to all three available antifungal drugs types. Resistance is especially concerning for patients with invasive fungal infections, frequently causing morbidity and mortality, especially in transplant recipients.2
60P is currently exploring the potential of tafenoquine (TAF), approved by regulators as an antimalarial, to combat other pathogens.3*
Cases and 1 Million deaths in the U.S. from COVID-19 infections
Annual deaths from malaria globally
Travelers to endemic regions per annum
Dengue infections per year
1025 Connecticut Ave. NW, Suite 1000, Washington, DC 20036